The demographics tell an important story too
Its once-daily dosing, compared to Ozempic and Wegovys once-weekly dosing, provides flexibility in titration for prescribers and increased adherence for patients who may not be able to keep track of what day of the week they inject
After 56 weeks of treatment, the average weight loss of the patients was 8.40 7.3 kg, and the most common adverse reactions were mild or moderate nausea and diarrhea
Note: Tirzepatide is technically a dual agonist (GLP-1 + GIP), meaning it targets two hormone receptors for potentially stronger effects
This partnership was the first time an FDA-cleared weight management aid or primary care product was made available at launch nationwide via telehealth providing immediate access to patients regardless of insurance status, zip code, or provider availability in their area
Symptoms like nausea, dehydration, and constipation can hinder your progress